DGAP-News: UMS AG Announces Extension of Buyback Period until February 1, 2012


DGAP-News: UMS United Medical Systems International AG / Key word(s):
Share Buyback
UMS AG Announces Extension of Buyback Period until February 1, 2012

24.01.2012 / 12:38

---------------------------------------------------------------------

UMS AG Announces Extension of Buyback Period until February 1, 2012

Hamburg, January 24, 2012 - Acting with the Supervisory Board's consent,
the Management Board of UMS United Medical Systems International AG,
Hamburg (ISIN DE 0005493654/WKN 549365), has today resolved to extend the
offer period for its previously announced tender offer by a further five
bank working days. The offer will now expire at Wednesday, February 1,
2012, midnight Central European Time, as the Board wishes to extend the
opportunity for UMS AG's shareholders to participate in the offer. The
buy-back price for each share continues to be EUR 6.35.

UMS AG has offered to buy back up to 300,000 shares within the current
share buy-back offer. Within the scope of the current public offer there
were registered 93,587 shares for buy-back.

Details of the offer are contained in the offer document and the first
amendment to the offer document, which are available on the Company's
website (http://www.umsag.com) under the menu item 'Investor
Relations/Share buy-back' and are or will be published on January 10, 2012
and on January 24, 2012 in the electronic Bundesanzeiger (German Federal
Gazette).

About UMS AG

UMS International AG is a provider of innovative healthcare delivery
concepts in the growth segment of high-tech medicine. UMS pioneered the
mobile deployment of high-class medical systems and markets a comprehensive
range of full-service solutions for hospitals and specialists. The
forward-looking concepts include complete services for the customer,
covering everything from system management to the provision of trained
application specialists. The UMS Group currently has over 220 employees
worldwide and serves over 650 customers.

Contact

Wiebke Budwasch, Phone: (040) 50 01 77-00, Fax: (040) 50 01 77-77, E-mail:
investor@umsag.com


End of Corporate News

---------------------------------------------------------------------

24.01.2012 Dissemination of a Corporate News, transmitted by DGAP - a
company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.

DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

---------------------------------------------------------------------


Language:    English                                               
Company:     UMS United Medical Systems International AG           
             Borsteler Chaussee 53                                 
             22453 Hamburg                                         
             Germany                                               
Phone:       +49 (0)40 - 500 177 - 00                              
Fax:         +49 (0)40 - 500 177 - 77                              
E-mail:      investor@umsag.com                                    
Internet:    www.umsag.com                                         
ISIN:        DE0005493654                                          
WKN:         549365                                                
Listed:      Regulierter Markt in Frankfurt (Prime Standard);      
             Freiverkehr in Berlin, Düsseldorf, Hamburg, München,  
             Stuttgart                                             
 
 
End of News    DGAP News-Service  
---------------------------------------------------------------------  
153764 24.01.2012